185 related articles for article (PubMed ID: 12836354)
1. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) with nuclease-resistance and high affinity for RNA.
Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Nucleic Acids Res Suppl; 2001; (1):241-2. PubMed ID: 12836354
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides.
Morita K; Takagi M; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Bioorg Med Chem; 2003 May; 11(10):2211-26. PubMed ID: 12713831
[TBL] [Abstract][Full Text] [Related]
3. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug.
Morita K; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
Bioorg Med Chem Lett; 2002 Jan; 12(1):73-6. PubMed ID: 11738576
[TBL] [Abstract][Full Text] [Related]
4. 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as next-generation antisense and antigene agents.
Koizumi M
Biol Pharm Bull; 2004 Apr; 27(4):453-6. PubMed ID: 15056846
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of ENA Nucleotides and ENA Oligonucleotides.
Morita K; Koizumi M
Curr Protoc Nucleic Acid Chem; 2018 Mar; 72(1):4.79.1-4.79.21. PubMed ID: 29927121
[TBL] [Abstract][Full Text] [Related]
6. Triplex formation with 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) having C3'-endo conformation at physiological pH.
Koizumi M; Morita K; Daigo M; Tsutsumi S; Abe K; Obika S; Imanishi T
Nucleic Acids Res; 2003 Jun; 31(12):3267-73. PubMed ID: 12799454
[TBL] [Abstract][Full Text] [Related]
7. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
[TBL] [Abstract][Full Text] [Related]
8. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
[TBL] [Abstract][Full Text] [Related]
9. 2'-O,4'-C-methyleneoxymethylene bridged nucleic acids (2',4'-BNA(COC)).
Hari Y; Kodama T; Imanishi T; Obika S
Methods Mol Biol; 2011; 764():31-57. PubMed ID: 21748632
[TBL] [Abstract][Full Text] [Related]
10. Nuclease resistant methylphosphonate-DNA/LNA chimeric oligonucleotides.
Nagahama K; Veedu RN; Wengel J
Bioorg Med Chem Lett; 2009 May; 19(10):2707-9. PubMed ID: 19375912
[TBL] [Abstract][Full Text] [Related]
11. ENA oligonucleotides as therapeutics.
Koizumi M
Curr Opin Mol Ther; 2006 Apr; 8(2):144-9. PubMed ID: 16610767
[TBL] [Abstract][Full Text] [Related]
12. N-Methyl substituted 2',4'- BNANC: a highly nuclease-resistant nucleic acid analogue with high-affinity RNA selective hybridization.
Miyashita K; Rahman SM; Seki S; Obika S; Imanishi T
Chem Commun (Camb); 2007 Sep; (36):3765-7. PubMed ID: 17851621
[TBL] [Abstract][Full Text] [Related]
13. Free-radical ring closure to conformationally locked α-L-carba-LNAs and synthesis of their oligos: nuclease stability, target RNA specificity, and elicitation of RNase H.
Li Q; Yuan F; Zhou C; Plashkevych O; Chattopadhyaya J
J Org Chem; 2010 Sep; 75(18):6122-40. PubMed ID: 20738147
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and properties of 2'-O,4'-C-spirocyclopropylene bridged nucleic acid (scpBNA), an analogue of 2',4'-BNA/LNA bearing a cyclopropane ring.
Yamaguchi T; Horiba M; Obika S
Chem Commun (Camb); 2015 Jun; 51(47):9737-40. PubMed ID: 25985928
[TBL] [Abstract][Full Text] [Related]
15. Five- and six-membered conformationally locked 2',4'-carbocyclic ribo-thymidines: synthesis, structure, and biochemical studies.
Srivastava P; Barman J; Pathmasiri W; Plashkevych O; Wenska M; Chattopadhyaya J
J Am Chem Soc; 2007 Jul; 129(26):8362-79. PubMed ID: 17552524
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and properties of a bridged nucleic acid with a perhydro-1,2-oxazin-3-one ring.
Shrestha AR; Hari Y; Yahara A; Osawa T; Obika S
J Org Chem; 2011 Dec; 76(24):9891-9. PubMed ID: 22059648
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl] modified nucleosides and oligonucleotides.
Prakash TP; Kawasaki AM; Fraser AS; Vasquez G; Manoharan M
J Org Chem; 2002 Jan; 67(2):357-69. PubMed ID: 11798305
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.
Honcharenko D; Barman J; Varghese OP; Chattopadhyaya J
Biochemistry; 2007 May; 46(19):5635-46. PubMed ID: 17411072
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, duplex-forming ability, enzymatic stability, and in vitro antisense potency of oligonucleotides including 2'-C,4'-C-ethyleneoxy-bridged thymidine derivatives.
Osawa T; Sawamura M; Wada F; Yamamoto T; Obika S; Hari Y
Org Biomol Chem; 2017 May; 15(18):3955-3963. PubMed ID: 28440828
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the inhibitory activity of oatp antisense oligonucleotides by incorporation of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) without a loss of subtype selectivity.
Takagi M; Morita K; Nakai D; Nakagomi R; Tokui T; Koizumi M
Biochemistry; 2004 Apr; 43(15):4501-10. PubMed ID: 15078096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
